COVIDNews CEPTON-INATO #1
3 April 2020 -
By Marc-Olivier Bévierre
Following the spectacular growth of the pandemic, numerous clinical trials have been initiated throughout the world in the past few weeks. CEPTON and INATO will present you an overview of these trials, updated on a regular basis. Here is the current status, based on the ANTICOVID data.
By Allan Beke, Phd, Matthias Bucher with the support of Inato team
CEPTON Strategies news
Here are all the reports and analysis we published along with the press articles about us
CEPTON is the author of many publications in the field of healthcare and pharmaceuticals and our partners are often interviewed by the specialized press.